Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis.

Al-Araji S, Moccia M, Jha A, Zhang L, Eshaghi A, Kanber B, Bianchi A, Yam C, Abdel-Mannan O, Goodkin O, Pontillo G, Hamed W, Mohamud S, Brownlee WJ, Chard DT, Chataway J, Chung K, De Angelis F, Hammam A, Hacohen Y, Khaleeli Z, Leary SM, Prados F, Swanton J, Thompson AJ, Trip SA, Wilson H, Wright S, Nachev P, Barkhof F, Toosy AT, Ciccarelli O.